GenMark Diagnostics, Inc. Provided earnings guidance for the fourth quarter and full year ended December 31, 2018. For the fourth quarter of 2018, the company's total revenue expected to be approximately $19.4 million, representing an increase of 21% over the fourth quarter of 2017 - ePlex revenue for the fourth quarter of 2018 expected to be approximately $12.1 million, an increase of approximately 110% versus the fourth quarter of 2017. For the full year of 2018, the company's total revenue expected to be approximately $70.8 million, representing an increase of 35% over 2017 - ePlex(R) revenue for the full year 2018 expected to be approximately $37.9 million, an increase of more than 270% over 2017.